PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
H.R. 3920, Trade and Globalization Assistance Act of 2007: trade adjustment assistance issues H.R. 5501, President's Emergency Plan For AIDS Relief (PEPFAR): intellectual property, access to medicines and public health H.R. 6180, Trade Reform, Accountability, Development, and Employment Act of 2008 (TRADE Act of 2008): intellectual property S. 1848, Trade and Globalization Adjustment Assistance Act of 2007: trade adjustment assistance issues S. 2731, President's Emergency Plan For AIDS Relief (PEPFAR): intellectual property, access to medicines and public health S. 3083, Trade Reform, Accountability, Development, and Employment Act of 2008 (TRADE Act of 2008): intellectual property Colombia Free Trade Agreement: intellectual property, market access and public health Korea Free Trade Agreement: intellectual property, market access and public health Implementation of Peru Free Trade Agreement: intellectual property, market access and public health World Health Organization (WHO) Intergovernmental Working Group on Public Health, Innovation and Intellectual Property (IGWG): intellectual property, access and public health World Trade Organization (WTO) intellectual property enforcement issues International market access and intellectual property issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT FILIPPONE | — |
| TOM MOORE | — |
| BYRON PATTERSON | — |
| BILLY TAUZIN | — |
| BRIAN CHRISTOPHER TOOHEY | — |
Copyright/Patent/Trademark CPT
H.R. 1902, Protecting Consumer Access to Generic Drugs Act of 2007: patent settlements H.R. 1908, Patent Reform Act of 2007: patent issues H.R. 4279, Prioritizing Resources and Organization for Intellectual Property Act of 2007: enforcement S. 316, Preserve Access to Affordable Generics Act: patent settlements S. 522, Intellectual Property Rights Enforcement Act: anti-counterfeiting and enforcement S. 1145, Patent Reform Act of 2007: patent issues S. 2317, Intellectual Property Enforcement Act of 2007: enforcement Senate reauthorization of the Federal Trade Commission (no bill introduced during reporting period) International intellectual property issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT FILIPPONE | — |
| ALAN GILBERT | — |
| JAMES BRYANT HALL | — |
| MIMI KNEUER | — |
| DAVID KORN | — |
| HALLIE AMANDA MARANCHICK | — |
| KENDRA MARTELLO | — |
| BYRON PATTERSON | — |
| HEATHER STRAWN | — |
| BILLY TAUZIN | — |
| STEVE TILTON | — |
| BRIAN CHRISTOPHER TOOHEY | — |
| DERRICK WHITE | — |
Health Issues HCR
H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007: importation H.R. 1038, Access to Life-Saving Medicine Act: follow-on biologics H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007: follow-on biologics H.R. 3610, Food and Drug Import Safety Act of 2007: import safety H.R. 5501, Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008: public health H.R. 5629, Pathway for Biosimilars Act: follow-on biologics H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008: anti-counterfeiting H.R. 6378, Strengthening of FDA Integrity Act of 2008: debarment S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007: importation S. 334, Healthy Americans Act: non-interference S. 623, Access to Life-Saving Medicine Act: follow-on biologics S. 1693, Wired for Health Care Quality Act: health information technology and health care quality and costs S. 1695, Biologics Price Competition and Innovation Act of 2007: follow-on biologics S. 2663, CPSC Reform Act: importation S. 2731, Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008: public health S. 3046, Access, Compassion, Care, and Ethics for Seriously Ill Patients Act (ACCESS Act): access to investigational drugs and related issues Food and Drug Administration Amendments Act (FDAAA) technical amendments (no bill introduced during reporting period) Pharmaceuticals in the environment issues Direct to Consumer (DTC) advertising issues Federal preemption issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| MAYA BERMINGHAM | — |
| RANDY BURKHOLDER | — |
| ANDREA JEAN DOUGLAS New | — |
| AMY CHEVALIER EFANTIS | Legislative Director - Rep. Artur Davis |
| ALAN GILBERT | — |
| JAMES BRYANT HALL | — |
| LAURYL DODSON JACKSON | — |
| MIMI KNEUER | — |
| DAVID KORN | — |
| HALLIE AMANDA MARANCHICK | — |
| KENDRA MARTELLO | — |
| TOM MOORE | — |
| BRIAN NAGLE | — |
| BYRON PATTERSON | — |
| MARJORIE E POWELL | — |
| LORI REILLY | — |
| RICHARD SMITH | — |
| HEATHER STRAWN | — |
| MATTHEW L SULKALA | Senior Legislative Assistant - Rep. Allen Boyd |
| BILLY TAUZIN | — |
| STEVE TILTON | — |
| JENNIFER VAN METER | — |
| DERRICK WHITE | — |
Medicare/Medicaid MMM
H.R. 1424, Paul Wellstone Mental Health and Addiction Equity Act of 2007: Medicaid rebate H.R. 3162, Children's Health and Medicare Protection Act of 2007: Medicaid rebate H.R. 4854, False Claims Act Correction Act of 2007: liability issues H.R. 5605, Physician Payments Sunshine Act of 2008: transparency issues H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008: comparative effectiveness, federal upper limit for Medicaid pharmacy reimbursement, electronic prescribing, Part D data disclosure, and other issues S. 558, Mental Health Parity Act of 2007: health insurance issues S. 2029, Physician Payments Sunshine Act of 2007: transparency issues S. 2041, False Claims Act Correction Act of 2007: liability issues S. 3101, Medicare Improvements for Patients and Providers Act of 2008: comparative effectiveness, federal upper limit for Medicaid pharmacy reimbursement, electronic prescribing, Part D data disclosure, and other issues S. 3118, Preserving Access to Medicare Act of 2008: electronic prescribing, Part D data disclosure, and other issues Medicaid Program; Prescription Drugs; Final Rule, 72 Fed. Reg 39142 (July 17, 2007) (AMP Rule): Medicaid
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREA MARLENE BERGMAN | — |
| MAYA BERMINGHAM | — |
| RANDY BURKHOLDER | — |
| ANDREA JEAN DOUGLAS New | — |
| AMY CHEVALIER EFANTIS | Legislative Director - Rep. Artur Davis |
| ALAN GILBERT | — |
| JAMES BRYANT HALL | — |
| LAURYL DODSON JACKSON | — |
| ANN KAPLAN | — |
| MIMI KNEUER | — |
| HALLIE AMANDA MARANCHICK | — |
| TOM MOORE | — |
| BYRON PATTERSON | — |
| LORI REILLY | — |
| RICHARD SMITH | — |
| HEATHER STRAWN | — |
| BILLY TAUZIN | — |
| STEVE TILTON | — |
| JENNIFER VAN METER | — |
| DERRICK WHITE | — |
| MICHAEL PAUL WOODY | Professional Staff - Senate HELP Committee |
Budget/Appropriations BUD
H.Con.Res. 312, Budget Resolution FY 2009: FDA, HHS and CMS budget issues, importation, non-interference S.Con.Res. 70, Budget Resolution FY 2009: FDA, HHS and CMS budget issues, importation, non-interference S. 3181, Making appropriations for the Department of Homeland Security for the fiscal year ending September 30, 2009, and for other purposes: importation FY'09 Agriculture Appropriations which could include FDA budget and importation issues (no bill introduced during reporting period) FY'09 Labor HHS Appropriations which could include HHS budget, importation, comparative effectiveness, and Part D benefit issues (no bill introduced during reporting period)
| Lobbyist | Covered position, as disclosed |
|---|---|
| MAYA BERMINGHAM | — |
| RANDY BURKHOLDER | — |
| ANDREA JEAN DOUGLAS New | — |
| AMY CHEVALIER EFANTIS | Legislative Director - Rep. Artur Davis |
| JAMES BRYANT HALL | — |
| VALERIE HARDIN JEWETT | Legis. Director - Rep. Rodney Frelinghuysen |
| MIMI KNEUER | — |
| KENDRA MARTELLO | — |
| BRIAN NAGLE | — |
| BYRON PATTERSON | — |
| LORI REILLY | — |
| RICHARD SMITH | — |
| MATTHEW L SULKALA | Senior Legislative Assistant - Rep. Allen Boyd |
| BILLY TAUZIN | — |
| STEVE TILTON | — |
| DERRICK WHITE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.